These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Goodwin AM Microvasc Res; 2007; 74(2-3):172-83. PubMed ID: 17631914 [TBL] [Abstract][Full Text] [Related]
7. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis. Singh JP Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185 [TBL] [Abstract][Full Text] [Related]
8. DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature. Shah AV; Bennett MR Eur J Pharmacol; 2017 Dec; 816():116-128. PubMed ID: 28347738 [TBL] [Abstract][Full Text] [Related]
9. In vitro models of angiogenesis. Ucuzian AA; Greisler HP World J Surg; 2007 Apr; 31(4):654-63. PubMed ID: 17372665 [TBL] [Abstract][Full Text] [Related]
10. Development of new drugs in angiogenesis. Ziche M; Donnini S; Morbidelli L Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: A curse or cure? Kalaivani V; Jaleel A Pharmacol Res; 2020 Aug; 158():104858. PubMed ID: 32430285 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Bikfalvi A; Bicknell R Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776 [TBL] [Abstract][Full Text] [Related]
13. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
14. Overview of angiogenesis: Biologic implications for antiangiogenic therapy. Ellis LM; Liu W; Ahmad SA; Fan F; Jung YD; Shaheen RM; Reinmuth N Semin Oncol; 2001 Oct; 28(5 Suppl 16):94-104. PubMed ID: 11706401 [TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
16. "ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. Quintavalle C; Garofalo M; Croce CM; Condorelli G Vascul Pharmacol; 2011 Oct; 55(4):87-91. PubMed ID: 21798370 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis: an organizing principle for drug discovery? Folkman J Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134 [TBL] [Abstract][Full Text] [Related]
18. Angiogenesis revisited - role and therapeutic potential of targeting endothelial metabolism. Stapor P; Wang X; Goveia J; Moens S; Carmeliet P J Cell Sci; 2014 Oct; 127(Pt 20):4331-41. PubMed ID: 25179598 [TBL] [Abstract][Full Text] [Related]
19. Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective. Missiaen R; Morales-Rodriguez F; Eelen G; Carmeliet P Vascul Pharmacol; 2017 Mar; 90():8-18. PubMed ID: 28082117 [TBL] [Abstract][Full Text] [Related]